Artículos de revistas
Guidelines for the management and treatment of periodic fever syndromes Cryopyrin-associated periodic syndromes (cryopyrinopathies - CAPS)
Fecha
2016-01-01Registro en:
Revista Brasileira de Reumatologia, v. 56, n. 1, p. 44-51, 2016.
1809-4570
0482-5004
10.1016/j.rbre.2015.08.020
2-s2.0-84960468843
2-s2.0-84960468843.pdf
7098310008371632
0000-0002-7631-7093
Autor
Universidade Federal de São Paulo (UNIFESP)
Universidade de São Paulo (USP)
Hospital da Criança de Brasília José Alencar (HCB)
Irmandade da Santa Casa de Misericórdia de São Paulo
Universidade Federal de Pernambuco (UFPE)
Universidade Federal do Pará (UFPA)
Universidade do Estado do Rio de Janeiro (UERJ)
Universidade Federal do Rio de Janeiro (UFRJ)
Hospital Pequeno Príncipe
Universidade Federal de Minas Gerais (UFMG)
Universidade Estadual Paulista (Unesp)
Institución
Resumen
Objective: To establish guidelines based on cientific evidences for the management of cryopyrin associated periodic syndromes. Description of the evidence collection method: The Guideline was prepared from 4 clinical questions that were structured through PICO (Patient, Intervention or indicator, Comparison and Outcome), to search in key primary scientific information databases. After defining the potential studies to support the recommendations, these were graduated considering their strength of evidence and grade of recommendation. Results: 1215 articles were retrieved and evaluated by title and abstract; from these, 42 articles were selected to support the recommendations. Recommendations: 1. The diagnosis of CAPS is based on clinical history and clinical manifestations, and later confirmed by genetic study. CAPS may manifest itself in three phenotypes: FCAS (mild form), MWS (intermediate form) and CINCA (severe form). Neurological, ophthalmic, otorhinolaryngological and radiological assessments may be highly valuable in distinguishing between syndromes; 2. The genetic diagnosis with NLRP3 gene analysis must be conducted in suspected cases of CAPS, i.e., individuals presenting before 20 years of age, recurrent episodes of inflammation expressed by a mild fever and urticaria; 3. Laboratory abnormalities include leukocytosis and elevated serum levels of inflammatory proteins; and 4. Targeted therapies directed against interleukin-1 lead to rapid remission of symptoms in most patients. However, there are important limitations on the long-term safety. None of the three anti-IL-1β inhibitors prevents progression of bone lesions.
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Cognitive And Behavioral Heterogeneity In Genetic Syndromes.
Pegoraro, Luiz F L; Steiner, Carlos E; Celeri, Eloisa H R V; Banzato, Claudio E M; Dalgalarrondo, Paulo -
Oral presentation of 10 patients with Cowden syndrome
Flores, IL; Romo, SA; Nava, FJT; Silva, ARD; Vargas, PA; de Almeida, OP; Lopes, MA -
Molecular and Cytogenetic Analyses on Brazilian Youths with Pervasive Developmental Disorders
Higino Estécio, Marcos Roberto; Fett-Conte, Agnes Cristina; Varella-Garcia, Marileila; Fridman, Cíntia; Silva, Ana Elizabete